$235.96 +3.00 (%) Shire Shs Sponsored American Deposit Receipt Repr 3 Shs - NASDAQ

Aug. 28, 2015 | 04:00 PM

Partner Headlines

  1. Benzinga's M&A Chatter for Tuesday August 18, 2015

    Benzinga | Aug. 18, 2015 | 19:15PM EST
  2. Undervalued Baxalta Shares Target of Acquisition by Shire Plc

    GuruFocus | Aug. 5, 2015 | 11:21AM EST
  3. Benzinga's M&A Chatter for Tuesday August 4, 2015

    Benzinga | Aug. 4, 2015 | 18:52PM EST
  4. Shire Spurned For Baxalta Bid

    IBD | Aug. 4, 2015 | 18:47PM EST
  5. Stock Indexes Near Day's Lows; Earnings, Buyouts Stir Medicals

    IBD | Aug. 4, 2015 | 13:25PM EST
  6. Mid-Day Market Update: Tuesday's Movers, China's New Short-Sell Rule, Greece's Stock Exchange

    Benzinga | Aug. 4, 2015 | 13:00PM EST
  7. Shire Offers $30 Billion For Ex-Baxter Unit Baxalta

    IBD | Aug. 4, 2015 | 10:46AM EST
  8. Benzinga's M&A Chatter for Monday Aug 3, 2015

    Benzinga | Aug. 3, 2015 | 19:49PM EST
  9. More Pharma Buyouts Ahead? 3 Top Stocks In Buy Range

    IBD | Aug. 3, 2015 | 18:21PM EST
  10. Stocks On Pace For Lackluster Start; Tyson Foods Tumbles

    IBD | Aug. 3, 2015 | 09:04AM EST
  11. Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset

    Benzinga | Aug. 3, 2015 | 07:01AM EST
  12. These 4 Foreign Drug Stocks Have Broken Out Recently

    IBD | Jul. 29, 2015 | 18:50PM EST
  13. Amgen Stock Clears Buy Point Ahead Of Earnings

    IBD | Jul. 28, 2015 | 14:33PM EST
  14. Valeant Posts Princely Gains

    IBD | Jul. 23, 2015 | 18:55PM EST
  15. Shire ups outlook on new drugs

    IBD | Jul. 23, 2015 | 18:50PM EST
  16. Shire Lifts 2015 Guidance On Strong Drug Pipeline

    IBD | Jul. 23, 2015 | 14:42PM EST
  17. Valeant Earnings Soar On M&A, Organic Sales Growth

    IBD | Jul. 23, 2015 | 09:37AM EST
  18. Top World Stocks In Bases Or Buy Range As Greece Votes

    IBD | Jul. 15, 2015 | 17:50PM EST
  19. Manning & Napier's Top 5 New Stock Buys of Q2

    GuruFocus | Jul. 9, 2015 | 02:00AM EST
  20. Manning & Napier Invests in Stake in Baidu

    GuruFocus | Jul. 8, 2015 | 17:00PM EST
  21. Andreas Halvorsen Increases Stake in Esperion Therapeutics

    GuruFocus | Jun. 30, 2015 | 00:18AM EST
  22. Daniel Loeb Parts With Stake in Alibaba

    GuruFocus | Jun. 24, 2015 | 19:01PM EST
  23. Smart Guru John Paulson Bullish on Actavis

    GuruFocus | Jun. 18, 2015 | 17:25PM EST
  24. When PIIGS Fly: The Power Of Ireland's Politics

    IBD | Jun. 11, 2015 | 18:54PM EST
  25. Benzinga's Weekend M&A Chatter

    Benzinga | Jun. 7, 2015 | 20:16PM EST
  26. Meet 8 Hot Med Stocks Among IBD's Big Cap Leaders

    IBD | Jun. 3, 2015 | 08:01AM EST
  27. John Paulson's Stocks Trading at Low P/E

    GuruFocus | May. 4, 2015 | 16:59PM EST
  28. Shire Reports A Good Quarter Promoted By Drug Sales

    GuruFocus | May. 4, 2015 | 00:11AM EST
  29. Shire sees double-digit gains

    IBD | Apr. 30, 2015 | 18:42PM EST
  30. Teva, Celgene, Novo Nordisk, Shire Report Q1 Earnings

    IBD | Apr. 30, 2015 | 10:48AM EST
  31. Benzinga's Top Initiations

    Benzinga | Apr. 29, 2015 | 09:36AM EST
  32. Pharmacyclics Shares Fall As Kyle Bass Files Petition To Cancel Patent

    Benzinga | Apr. 20, 2015 | 16:09PM EST
  33. Goldman's Monster Q1 Spurred By Megadeals, Volatility

    IBD | Apr. 16, 2015 | 11:32AM EST
  34. Goldman's Q1 Seen Lifted By Gyrating Stocks, Big M&A

    IBD | Apr. 13, 2015 | 17:26PM EST
  35. US Stock Futures Edge Higher Ahead Of Economic Data

    Benzinga | Mar. 2, 2015 | 07:36AM EST
  36. Cyberonics Soars On Earnings Beat, Tax Inversion Deal

    IBD | Feb. 26, 2015 | 13:58PM EST
  37. Lannett Joins Big-Game Hunt For Drugmaker Acquisitions

    IBD | Feb. 24, 2015 | 15:58PM EST
  38. Valeant Pharmaceuticals Finally Zeros In On Salix Pharmaceuticals

    GuruFocus | Feb. 24, 2015 | 12:09PM EST
  39. Drugmaker Mylan Takes Part In Pharma Feeding Frenzy

    IBD | Feb. 23, 2015 | 14:59PM EST
  40. Pharma M&A: Bristol-Myers, Valeant Make Deals

    IBD | Feb. 23, 2015 | 12:41PM EST
  41. Valeant Pharmaceuticals Will Buy Salix For $14.5 Billion

    IBD | Feb. 22, 2015 | 17:46PM EST
  42. Why Muscular Dystrophy Is Biotech's Favorite Orphan

    IBD | Feb. 19, 2015 | 16:59PM EST
  43. A Look At Dan Loeb's Diversified 13F

    Benzinga | Feb. 18, 2015 | 18:04PM EST
  44. Paulson & Company's Q4 Moves: Healthcare And Beyond

    Benzinga | Feb. 18, 2015 | 16:12PM EST
  45. Benzinga's Weekend M&A Chatter

    Benzinga | Feb. 16, 2015 | 17:14PM EST
  46. Three Pharma Majors In The Run To Acquire Salix

    GuruFocus | Feb. 16, 2015 | 12:30PM EST
  47. Salix, Top Drug Stocks Rally As Merger Mania Heats Up

    IBD | Feb. 13, 2015 | 18:08PM EST
  48. Benzinga's M&A Chatter for Thursday February 12, 2015

    Benzinga | Feb. 12, 2015 | 20:18PM EST
  49. Shire rises on NPS potential

    IBD | Feb. 12, 2015 | 18:30PM EST
  50. Shire Moves Higher On NPS Potential; Q4 Earnings Miss

    IBD | Feb. 12, 2015 | 10:45AM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!